DE69311126T2 - ISOCARBACYCLIN MIT MODIFIZIERTER ALPHA(a)-KETTE UND VERFAHREN ZU DESSEN HERSTELLUNG - Google Patents
ISOCARBACYCLIN MIT MODIFIZIERTER ALPHA(a)-KETTE UND VERFAHREN ZU DESSEN HERSTELLUNGInfo
- Publication number
- DE69311126T2 DE69311126T2 DE69311126T DE69311126T DE69311126T2 DE 69311126 T2 DE69311126 T2 DE 69311126T2 DE 69311126 T DE69311126 T DE 69311126T DE 69311126 T DE69311126 T DE 69311126T DE 69311126 T2 DE69311126 T2 DE 69311126T2
- Authority
- DE
- Germany
- Prior art keywords
- group
- methyl
- hydroxy
- hydroxybicyclo
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 21
- JANVYOZZTKSZGN-WCAFQOMDSA-N 5-[(3as,5r,6r,6as)-5-hydroxy-6-[(e,3s)-3-hydroxyoct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]pentanoic acid Chemical compound C1=C(CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 JANVYOZZTKSZGN-WCAFQOMDSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title description 3
- -1 thiophenediyl Chemical group 0.000 claims abstract description 93
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims abstract description 8
- 125000002993 cycloalkylene group Chemical group 0.000 claims abstract description 6
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 17
- 150000003752 zinc compounds Chemical class 0.000 claims description 17
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 11
- 150000001768 cations Chemical class 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 8
- 239000007795 chemical reaction product Substances 0.000 claims description 8
- 125000005843 halogen group Chemical group 0.000 claims description 8
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 5
- 238000010511 deprotection reaction Methods 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 3
- 229930195733 hydrocarbon Natural products 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 125000004434 sulfur atom Chemical group 0.000 claims description 3
- 238000005755 formation reaction Methods 0.000 claims description 2
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical class [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract description 10
- 230000002401 inhibitory effect Effects 0.000 abstract description 9
- 230000006820 DNA synthesis Effects 0.000 abstract description 4
- 102000043827 human Smooth muscle Human genes 0.000 abstract description 4
- 108700038605 human Smooth muscle Proteins 0.000 abstract description 4
- 206010072810 Vascular wall hypertrophy Diseases 0.000 abstract 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 38
- 150000001875 compounds Chemical class 0.000 description 34
- 239000000203 mixture Substances 0.000 description 31
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 23
- 239000007788 liquid Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 20
- FGTJJHCZWOVVNH-UHFFFAOYSA-N tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane Chemical class CC(C)(C)[Si](C)(C)O[Si](C)(C)C(C)(C)C FGTJJHCZWOVVNH-UHFFFAOYSA-N 0.000 description 18
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 16
- 210000004204 blood vessel Anatomy 0.000 description 13
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical group O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 13
- 229960001123 epoprostenol Drugs 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 239000007858 starting material Substances 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 150000003815 prostacyclins Chemical class 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 10
- 150000002430 hydrocarbons Chemical group 0.000 description 10
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 8
- 239000000376 reactant Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 206010020880 Hypertrophy Diseases 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 7
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 6
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 5
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 5
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 5
- 150000004820 halides Chemical class 0.000 description 5
- 229910052736 halogen Inorganic materials 0.000 description 5
- 150000002367 halogens Chemical group 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000007810 chemical reaction solvent Substances 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- NPXOIGSBRLCOSD-UHFFFAOYSA-N methyl 3-iodobenzoate Chemical compound COC(=O)C1=CC=CC(I)=C1 NPXOIGSBRLCOSD-UHFFFAOYSA-N 0.000 description 3
- NLWBJPPMPLPZIE-UHFFFAOYSA-N methyl 4-(bromomethyl)benzoate Chemical compound COC(=O)C1=CC=C(CBr)C=C1 NLWBJPPMPLPZIE-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000005051 trimethylchlorosilane Substances 0.000 description 3
- OSBWVNMSHWNTMS-RLQYIGOUSA-N (1r,2r,3as,6ar)-1-[(e,3s)-3-cyclopentyl-3-hydroxyprop-1-enyl]-5-methylidene-2,3,3a,4,6,6a-hexahydro-1h-pentalen-2-ol Chemical compound C1([C@@H](\C=C\[C@@H]2[C@@H]3CC(=C)C[C@H]3C[C@H]2O)O)CCCC1 OSBWVNMSHWNTMS-RLQYIGOUSA-N 0.000 description 2
- VIMMECPCYZXUCI-MIMFYIINSA-N (4s,6r)-6-[(1e)-4,4-bis(4-fluorophenyl)-3-(1-methyltetrazol-5-yl)buta-1,3-dienyl]-4-hydroxyoxan-2-one Chemical compound CN1N=NN=C1C(\C=C\[C@@H]1OC(=O)C[C@@H](O)C1)=C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 VIMMECPCYZXUCI-MIMFYIINSA-N 0.000 description 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- XZFRIPGNUQRGPI-WLPVIMDJSA-N Carbacyclin Chemical compound C1\C(=C\CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 XZFRIPGNUQRGPI-WLPVIMDJSA-N 0.000 description 2
- 241000557626 Corvus corax Species 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 150000002148 esters Chemical group 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229910003002 lithium salt Inorganic materials 0.000 description 2
- 159000000002 lithium salts Chemical class 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 2
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 2
- QKASDIPENBEWBU-UHFFFAOYSA-N methyl 2-(bromomethyl)benzoate Chemical compound COC(=O)C1=CC=CC=C1CBr QKASDIPENBEWBU-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IMSDHCCUPOIIRD-XVNIHMCQSA-N (1r,2r,3as,6ar)-1-[(e)-4-ethenyl-4-hydroxyoct-1-enyl]-5-methylidene-2,3,3a,4,6,6a-hexahydro-1h-pentalen-2-ol Chemical compound C1C(=C)C[C@H]2[C@@H](/C=C/CC(O)(CCCC)C=C)[C@H](O)C[C@@H]21 IMSDHCCUPOIIRD-XVNIHMCQSA-N 0.000 description 1
- XCAJWMCAZQHPQA-XVNIHMCQSA-N (1r,2r,3as,6ar)-1-[(e)-4-hydroxy-4-methylnon-1-enyl]-5-methylidene-2,3,3a,4,6,6a-hexahydro-1h-pentalen-2-ol Chemical compound C1C(=C)C[C@H]2[C@@H](/C=C/CC(C)(O)CCCCC)[C@H](O)C[C@@H]21 XCAJWMCAZQHPQA-XVNIHMCQSA-N 0.000 description 1
- BEFWULSINHIMIT-ZSGSWNGISA-N (1r,2r,3as,6ar)-1-[(e,3s)-3-ethenyl-3-hydroxyoct-1-enyl]-5-methylidene-2,3,3a,4,6,6a-hexahydro-1h-pentalen-2-ol Chemical compound C1C(=C)C[C@H]2[C@@H](/C=C/[C@@](O)(C=C)CCCCC)[C@H](O)C[C@@H]21 BEFWULSINHIMIT-ZSGSWNGISA-N 0.000 description 1
- BBHDWLXQGAGDMC-PZFMRPBJSA-N (1r,2r,3as,6ar)-1-[(e,3s)-3-hydroxy-3-methyloct-1-enyl]-5-methylidene-2,3,3a,4,6,6a-hexahydro-1h-pentalen-2-ol Chemical compound C1C(=C)C[C@H]2[C@@H](/C=C/[C@@](C)(O)CCCCC)[C@H](O)C[C@@H]21 BBHDWLXQGAGDMC-PZFMRPBJSA-N 0.000 description 1
- MZJUBGJWVQVMRU-SRSSEHASSA-N (1r,2r,3as,6ar)-1-[(e,3s)-3-hydroxynon-1-enyl]-5-methylidene-2,3,3a,4,6,6a-hexahydro-1h-pentalen-2-ol Chemical compound C1C(=C)C[C@H]2[C@@H](/C=C/[C@@H](O)CCCCCC)[C@H](O)C[C@@H]21 MZJUBGJWVQVMRU-SRSSEHASSA-N 0.000 description 1
- AZWUAYXNJGMDMZ-GGKSNXOKSA-N (1r,2r,3as,6ar)-1-[(e,3s)-3-hydroxyoct-1-enyl]-5-methylidene-2,3,3a,4,6,6a-hexahydro-1h-pentalen-2-ol Chemical compound C1C(=C)C[C@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 AZWUAYXNJGMDMZ-GGKSNXOKSA-N 0.000 description 1
- HJXSIGPOXDIODK-WLECZJOZSA-N (1r,2r,3as,6ar)-1-[(e,3s,5r)-3-hydroxy-5-methylnon-1-enyl]-5-methylidene-2,3,3a,4,6,6a-hexahydro-1h-pentalen-2-ol Chemical compound C1C(=C)C[C@H]2[C@@H](/C=C/[C@@H](O)C[C@H](C)CCCC)[C@H](O)C[C@@H]21 HJXSIGPOXDIODK-WLECZJOZSA-N 0.000 description 1
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 description 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- 125000006557 (C2-C5) alkylene group Chemical group 0.000 description 1
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 description 1
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 description 1
- SYTBZMRGLBWNTM-SNVBAGLBSA-N (R)-flurbiprofen Chemical compound FC1=CC([C@H](C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-SNVBAGLBSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- LAPNHUWEHSVXKE-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxyperoxy)ethane Chemical compound CCOCCOOOCCOCC LAPNHUWEHSVXKE-UHFFFAOYSA-N 0.000 description 1
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 1
- AVKPKPFXSIOSHG-GKIKLBCDSA-N 2-[2-[(3aS,5R,6S,6aS)-5-hydroxy-6-[(E,3S)-3-hydroxy-5-methylnon-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]ethyl]benzoic acid Chemical compound C([C@@H]1[C@@H]([C@@H]([C@H](O)C1)/C=C/[C@@H](O)CC(C)CCCC)C1)=C1CCc1ccccc1C(O)=O AVKPKPFXSIOSHG-GKIKLBCDSA-N 0.000 description 1
- GOHKJVKDOKKOGY-JLNDHFFNSA-N 2-[2-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxy-4,4-dimethyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]ethyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@H](O)C(C)(C)CCCC)=C1CCC1=CC=CC=C1C(O)=O GOHKJVKDOKKOGY-JLNDHFFNSA-N 0.000 description 1
- NTZGIJSNOWUJEE-GFZGUYFGSA-N 2-[2-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxy-5-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]ethyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)CC(C)CCC)=C1CCC1=CC=CC=C1C(O)=O NTZGIJSNOWUJEE-GFZGUYFGSA-N 0.000 description 1
- LJGMCHWVEXITFD-HUIZADCRSA-N 2-[2-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxyoct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]ethyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)CCCCC)=C1CCC1=CC=CC=C1C(O)=O LJGMCHWVEXITFD-HUIZADCRSA-N 0.000 description 1
- USGMUYLRHGACFW-JHRVGKCBSA-N 2-[2-[(3as,5r,6s,6as)-6-[(e,3s)-3-cyclopentyl-3-hydroxyprop-1-enyl]-5-hydroxy-1,3a,4,5,6,6a-hexahydropentalen-2-yl]ethyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)C2CCCC2)=C1CCC1=CC=CC=C1C(O)=O USGMUYLRHGACFW-JHRVGKCBSA-N 0.000 description 1
- XPOHPALHRVSGNM-UIQIDZNJSA-N 2-[3-[(3aS,5R,6S,6aS)-5-hydroxy-6-[(E,3S)-3-hydroxy-5-methylnon-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]propyl]benzoic acid Chemical compound C([C@@H]1[C@@H]([C@@H]([C@H](O)C1)/C=C/[C@@H](O)CC(C)CCCC)C1)=C1CCCc1ccccc1C(O)=O XPOHPALHRVSGNM-UIQIDZNJSA-N 0.000 description 1
- DPENULFDHGFORP-JWUCFQOUSA-N 2-[3-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxy-4-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]propyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)C(C)CCCC)=C1CCCC1=CC=CC=C1C(O)=O DPENULFDHGFORP-JWUCFQOUSA-N 0.000 description 1
- HSAVSTNCFSLVBY-GKIKLBCDSA-N 2-[3-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxy-5-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]propyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)CC(C)CCC)=C1CCCC1=CC=CC=C1C(O)=O HSAVSTNCFSLVBY-GKIKLBCDSA-N 0.000 description 1
- DUQYADHNDDOPEP-IEBYUTTMSA-N 2-[3-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,4s)-4-hydroxy-4-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]propyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/C[C@@](C)(O)CCCC)=C1CCCC1=CC=CC=C1C(O)=O DUQYADHNDDOPEP-IEBYUTTMSA-N 0.000 description 1
- DDRJYFMAPGDYGI-DOSBXVBXSA-N 2-[3-[(3as,5r,6s,6as)-6-[(e)-4-ethenyl-4-hydroxyoct-1-enyl]-5-hydroxy-1,3a,4,5,6,6a-hexahydropentalen-2-yl]propyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/CC(O)(CCCC)C=C)=C1CCCC1=CC=CC=C1C(O)=O DDRJYFMAPGDYGI-DOSBXVBXSA-N 0.000 description 1
- LSSOJCHAUYXRJY-QBMQXPIRSA-N 2-[3-[(3as,5r,6s,6as)-6-[(e,3s)-3-cyclopentyl-3-hydroxyprop-1-enyl]-5-hydroxy-1,3a,4,5,6,6a-hexahydropentalen-2-yl]propyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)C2CCCC2)=C1CCCC1=CC=CC=C1C(O)=O LSSOJCHAUYXRJY-QBMQXPIRSA-N 0.000 description 1
- OOKXFBGHIKOFCL-OKPNTENOSA-N 2-[4-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxy-4-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]butyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)C(C)CCCC)=C1CCCCC1=CC=CC=C1C(O)=O OOKXFBGHIKOFCL-OKPNTENOSA-N 0.000 description 1
- MVDSCNOQMDDWSR-JNHHLVPHSA-N 2-[4-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxyoct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]butyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)CCCCC)=C1CCCCC1=CC=CC=C1C(O)=O MVDSCNOQMDDWSR-JNHHLVPHSA-N 0.000 description 1
- YRUUQOKIYYGKSK-OPIYFKSESA-N 2-[4-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,4r)-4-hydroxy-4-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]butyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/C[C@](C)(O)CCCC)=C1CCCCC1=CC=CC=C1C(O)=O YRUUQOKIYYGKSK-OPIYFKSESA-N 0.000 description 1
- YRUUQOKIYYGKSK-WPLGAIPKSA-N 2-[4-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,4s)-4-hydroxy-4-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]butyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/C[C@@](C)(O)CCCC)=C1CCCCC1=CC=CC=C1C(O)=O YRUUQOKIYYGKSK-WPLGAIPKSA-N 0.000 description 1
- TZFFRUJAFXXJIG-BTGJPNGWSA-N 2-[5-[(3aS,5R,6S,6aS)-5-hydroxy-6-[(E,4S)-4-hydroxy-4-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]pentyl]benzoic acid Chemical compound C([C@@H]1[C@@H]([C@@H]([C@H](O)C1)/C=C/C[C@@](C)(O)CCCC)C1)=C1CCCCCc1ccccc1C(O)=O TZFFRUJAFXXJIG-BTGJPNGWSA-N 0.000 description 1
- ZEVDJHJCZXPHAY-MHQXIKQASA-N 2-[5-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxy-4,4-dimethyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]pentyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@H](O)C(C)(C)CCCC)=C1CCCCCC1=CC=CC=C1C(O)=O ZEVDJHJCZXPHAY-MHQXIKQASA-N 0.000 description 1
- UTMNVONFTUCVNJ-QHKKPFIRSA-N 2-[5-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxy-5-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]pentyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)CC(C)CCC)=C1CCCCCC1=CC=CC=C1C(O)=O UTMNVONFTUCVNJ-QHKKPFIRSA-N 0.000 description 1
- QJVHHUSOTQYXEB-BVHVZPTQSA-N 2-[5-[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxyoct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]pentyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)CCCCC)=C1CCCCCC1=CC=CC=C1C(O)=O QJVHHUSOTQYXEB-BVHVZPTQSA-N 0.000 description 1
- DPNJSDLIVNJXBD-IQYNPLHDSA-N 2-[5-[(3as,5r,6s,6as)-6-[(e)-4-ethenyl-4-hydroxyoct-1-enyl]-5-hydroxy-1,3a,4,5,6,6a-hexahydropentalen-2-yl]pentyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/CC(O)(CCCC)C=C)=C1CCCCCC1=CC=CC=C1C(O)=O DPNJSDLIVNJXBD-IQYNPLHDSA-N 0.000 description 1
- RPHGCGLTNWLDMS-RJFDZDSHSA-N 2-[[(3aS,5R,6S,6aS)-5-hydroxy-6-[(E,4S)-4-hydroxy-4-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]methyl]benzoic acid Chemical compound C([C@@H]1[C@@H]([C@@H]([C@H](O)C1)/C=C/C[C@@](C)(O)CCCC)C1)=C1Cc1ccccc1C(O)=O RPHGCGLTNWLDMS-RJFDZDSHSA-N 0.000 description 1
- MWYZTYPYZREUKQ-ARJPBUSCSA-N 2-[[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxy-4,4-dimethyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]methyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@H](O)C(C)(C)CCCC)=C1CC1=CC=CC=C1C(O)=O MWYZTYPYZREUKQ-ARJPBUSCSA-N 0.000 description 1
- QPVMFMTZKOUCBV-JQALRQCTSA-N 2-[[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxy-4-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]methyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)C(C)CCCC)=C1CC1=CC=CC=C1C(O)=O QPVMFMTZKOUCBV-JQALRQCTSA-N 0.000 description 1
- JBTSCHFIIJCMNC-YGHSAKCVSA-N 2-[[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxy-5-methylnon-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]methyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)CC(C)CCCC)=C1CC1=CC=CC=C1C(O)=O JBTSCHFIIJCMNC-YGHSAKCVSA-N 0.000 description 1
- VTRUGVCKYJGBNS-BWJQJBBHSA-N 2-[[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxyoct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]methyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)CCCCC)=C1CC1=CC=CC=C1C(O)=O VTRUGVCKYJGBNS-BWJQJBBHSA-N 0.000 description 1
- RPHGCGLTNWLDMS-XLYDQPKCSA-N 2-[[(3as,5r,6s,6as)-5-hydroxy-6-[(e,4r)-4-hydroxy-4-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]methyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/C[C@](C)(O)CCCC)=C1CC1=CC=CC=C1C(O)=O RPHGCGLTNWLDMS-XLYDQPKCSA-N 0.000 description 1
- IHSVHXRXATUJTI-KWBTUIJISA-N 2-[[(3as,5r,6s,6as)-6-[(e)-4-ethenyl-4-hydroxyoct-1-enyl]-5-hydroxy-1,3a,4,5,6,6a-hexahydropentalen-2-yl]methyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/CC(O)(CCCC)C=C)=C1CC1=CC=CC=C1C(O)=O IHSVHXRXATUJTI-KWBTUIJISA-N 0.000 description 1
- LNDMHDQOZVFQQH-GONHWKFQSA-N 2-[[(3as,5r,6s,6as)-6-[(e,3s)-3-cyclopentyl-3-hydroxyprop-1-enyl]-5-hydroxy-1,3a,4,5,6,6a-hexahydropentalen-2-yl]methyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)C2CCCC2)=C1CC1=CC=CC=C1C(O)=O LNDMHDQOZVFQQH-GONHWKFQSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- JQBKVDHJRKJHQZ-NZIXHETNSA-N 3-[[(3as,5r,6s,6as)-5-hydroxy-6-[(e,3s)-3-hydroxyoct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]methyl]benzoic acid Chemical compound C([C@H]1C[C@@H](O)[C@H]([C@H]1C1)/C=C/[C@@H](O)CCCCC)=C1CC1=CC=CC(C(O)=O)=C1 JQBKVDHJRKJHQZ-NZIXHETNSA-N 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241001124569 Lycaenidae Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- KRKBKUOPSVGGBX-XPCPJXBESA-N [(3ar,4r,5r,6as)-5-[tert-butyl(dimethyl)silyl]oxy-4-[(e,4r)-4-hydroxy-4-methyloct-1-enyl]-2-methylidene-3,3a,4,5,6,6a-hexahydro-1h-pentalen-1-yl] diphenyl phosphate Chemical compound C([C@@H]1[C@@H]2C[C@H]([C@@H]1/C=C/C[C@](C)(O)CCCC)O[Si](C)(C)C(C)(C)C)C(=C)C2OP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 KRKBKUOPSVGGBX-XPCPJXBESA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- MPRWIVBRDAXEAF-UHFFFAOYSA-N acetyloxy ethaneperoxoate Chemical compound CC(=O)OOOC(C)=O MPRWIVBRDAXEAF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000005002 aryl methyl group Chemical group 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007805 chemical reaction reactant Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000004699 copper complex Chemical class 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 150000002496 iodine Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- HNNUQHJWFIPTLJ-UHFFFAOYSA-N methyl 4-(2-bromoethyl)benzoate Chemical compound COC(=O)C1=CC=C(CCBr)C=C1 HNNUQHJWFIPTLJ-UHFFFAOYSA-N 0.000 description 1
- KOLIWBZDVYITNS-UHFFFAOYSA-N methyl 4-(2-chloroethyl)benzoate Chemical compound COC(=O)C1=CC=C(CCCl)C=C1 KOLIWBZDVYITNS-UHFFFAOYSA-N 0.000 description 1
- PLQNTYFWSCFMQP-UHFFFAOYSA-N methyl 4-(2-fluoroethyl)benzoate Chemical compound COC(=O)C1=CC=C(CCF)C=C1 PLQNTYFWSCFMQP-UHFFFAOYSA-N 0.000 description 1
- FEBZFUASXKRIMS-UHFFFAOYSA-N methyl 4-(2-iodoethyl)benzoate Chemical compound COC(=O)C1=CC=C(CCI)C=C1 FEBZFUASXKRIMS-UHFFFAOYSA-N 0.000 description 1
- VMHPVAWXMHRICK-UHFFFAOYSA-N methyl 4-(3-bromopropyl)benzoate Chemical compound COC(=O)C1=CC=C(CCCBr)C=C1 VMHPVAWXMHRICK-UHFFFAOYSA-N 0.000 description 1
- FUGRAIDAYOLEJF-UHFFFAOYSA-N methyl 4-(3-chloropropyl)benzoate Chemical compound COC(=O)C1=CC=C(CCCCl)C=C1 FUGRAIDAYOLEJF-UHFFFAOYSA-N 0.000 description 1
- RVCSRTAEGZKZTQ-UHFFFAOYSA-N methyl 4-(3-fluoropropyl)benzoate Chemical compound COC(=O)C1=CC=C(CCCF)C=C1 RVCSRTAEGZKZTQ-UHFFFAOYSA-N 0.000 description 1
- LZBFGUOKEIONOA-UHFFFAOYSA-N methyl 4-(3-iodopropyl)benzoate Chemical compound COC(=O)C1=CC=C(CCCI)C=C1 LZBFGUOKEIONOA-UHFFFAOYSA-N 0.000 description 1
- NVHBDTYUOUJQAI-UHFFFAOYSA-N methyl 4-(4-bromobutyl)benzoate Chemical compound COC(=O)C1=CC=C(CCCCBr)C=C1 NVHBDTYUOUJQAI-UHFFFAOYSA-N 0.000 description 1
- OBYFRRZJOHOUFA-UHFFFAOYSA-N methyl 4-(4-chlorobutyl)benzoate Chemical compound COC(=O)C1=CC=C(CCCCCl)C=C1 OBYFRRZJOHOUFA-UHFFFAOYSA-N 0.000 description 1
- QQXFGRQLCAMOFV-UHFFFAOYSA-N methyl 4-(4-fluorobutyl)benzoate Chemical compound COC(=O)C1=CC=C(CCCCF)C=C1 QQXFGRQLCAMOFV-UHFFFAOYSA-N 0.000 description 1
- JQQLZIUNFOEENM-UHFFFAOYSA-N methyl 4-(4-iodobutyl)benzoate Chemical compound COC(=O)C1=CC=C(CCCCI)C=C1 JQQLZIUNFOEENM-UHFFFAOYSA-N 0.000 description 1
- SATDLKYRVXFXRE-UHFFFAOYSA-N methyl 4-(chloromethyl)benzoate Chemical compound COC(=O)C1=CC=C(CCl)C=C1 SATDLKYRVXFXRE-UHFFFAOYSA-N 0.000 description 1
- NXEAZHKNSTZSPA-UHFFFAOYSA-N methyl 4-(fluoromethyl)benzoate Chemical compound COC(=O)C1=CC=C(CF)C=C1 NXEAZHKNSTZSPA-UHFFFAOYSA-N 0.000 description 1
- LNOWIMOOHDUYNJ-UHFFFAOYSA-N methyl 4-(iodomethyl)benzoate Chemical compound COC(=O)C1=CC=C(CI)C=C1 LNOWIMOOHDUYNJ-UHFFFAOYSA-N 0.000 description 1
- CZNGTXVOZOWWKM-UHFFFAOYSA-N methyl 4-bromobenzoate Chemical compound COC(=O)C1=CC=C(Br)C=C1 CZNGTXVOZOWWKM-UHFFFAOYSA-N 0.000 description 1
- LXNFVVDCCWUUKC-UHFFFAOYSA-N methyl 4-chlorobenzoate Chemical compound COC(=O)C1=CC=C(Cl)C=C1 LXNFVVDCCWUUKC-UHFFFAOYSA-N 0.000 description 1
- MSEBQGULDWDIRW-UHFFFAOYSA-N methyl 4-fluorobenzoate Chemical compound COC(=O)C1=CC=C(F)C=C1 MSEBQGULDWDIRW-UHFFFAOYSA-N 0.000 description 1
- DYUWQWMXZHDZOR-UHFFFAOYSA-N methyl 4-iodobenzoate Chemical compound COC(=O)C1=CC=C(I)C=C1 DYUWQWMXZHDZOR-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000006462 rearrangement reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- RWWYLEGWBNMMLJ-YSOARWBDSA-N remdesivir Chemical compound NC1=NC=NN2C1=CC=C2[C@]1([C@@H]([C@@H]([C@H](O1)CO[P@](=O)(OC1=CC=CC=C1)N[C@H](C(=O)OCC(CC)CC)C)O)O)C#N RWWYLEGWBNMMLJ-YSOARWBDSA-N 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000005650 substituted phenylene group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- KJTULOVPMGUBJS-UHFFFAOYSA-N tert-butyl-[tert-butyl(diphenyl)silyl]oxy-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)O[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 KJTULOVPMGUBJS-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000004187 tetrahydropyran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
- 125000005490 tosylate group Chemical group 0.000 description 1
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/16—Unsaturated compounds
- C07C61/35—Unsaturated compounds having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/19—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
- C07C405/0075—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
- C07C405/0083—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26608492 | 1992-10-05 | ||
| PCT/JP1993/001407 WO1994007838A1 (fr) | 1992-10-05 | 1993-10-01 | ISOCARBACYCLINE A CHAINE α MODIFIEE ET PROCEDE POUR SA PRODUCTION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69311126D1 DE69311126D1 (de) | 1997-07-03 |
| DE69311126T2 true DE69311126T2 (de) | 1997-11-06 |
Family
ID=17426122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69311126T Expired - Fee Related DE69311126T2 (de) | 1992-10-05 | 1993-10-01 | ISOCARBACYCLIN MIT MODIFIZIERTER ALPHA(a)-KETTE UND VERFAHREN ZU DESSEN HERSTELLUNG |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5532408A (enExample) |
| EP (1) | EP0664281B1 (enExample) |
| KR (1) | KR100199124B1 (enExample) |
| AT (1) | ATE153652T1 (enExample) |
| CA (1) | CA2146361A1 (enExample) |
| DE (1) | DE69311126T2 (enExample) |
| WO (1) | WO1994007838A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3086595A (en) * | 1994-08-09 | 1996-03-07 | Teijin Limited | Vascular smooth muscle cell migration inhibitor |
| WO2023067518A1 (en) * | 2021-10-20 | 2023-04-27 | Assembly Biosciences, Inc. | Process |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4338457A (en) * | 1980-02-28 | 1982-07-06 | The Upjohn Company | Composition and process |
| HU190007B (en) * | 1982-05-06 | 1986-08-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | Process for producing new aromatic prostacylin analogues |
| JPS62258330A (ja) * | 1986-05-01 | 1987-11-10 | Teijin Ltd | ６，７−二置換−２−ヒドロキシ−３−メチレンビシクロ〔３．３．０〕オクタン類の製造法 |
| JPH0645575B2 (ja) * | 1987-06-04 | 1994-06-15 | 帝人株式会社 | ３―メチレン―２，６，７―三置換ビシクロ［３．３．０オクタン類 |
| JP3178150B2 (ja) * | 1993-03-12 | 2001-06-18 | 宇部興産株式会社 | 採血装置 |
-
1993
- 1993-10-01 US US08/411,649 patent/US5532408A/en not_active Expired - Fee Related
- 1993-10-01 CA CA002146361A patent/CA2146361A1/en not_active Abandoned
- 1993-10-01 KR KR1019950701298A patent/KR100199124B1/ko not_active Expired - Fee Related
- 1993-10-01 EP EP93921098A patent/EP0664281B1/en not_active Expired - Lifetime
- 1993-10-01 WO PCT/JP1993/001407 patent/WO1994007838A1/ja not_active Ceased
- 1993-10-01 AT AT93921098T patent/ATE153652T1/de not_active IP Right Cessation
- 1993-10-01 DE DE69311126T patent/DE69311126T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0664281A1 (en) | 1995-07-26 |
| KR950703511A (ko) | 1995-09-20 |
| EP0664281B1 (en) | 1997-05-28 |
| US5532408A (en) | 1996-07-02 |
| EP0664281A4 (enExample) | 1995-08-16 |
| KR100199124B1 (ko) | 1999-06-15 |
| CA2146361A1 (en) | 1994-04-14 |
| WO1994007838A1 (fr) | 1994-04-14 |
| ATE153652T1 (de) | 1997-06-15 |
| DE69311126D1 (de) | 1997-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1201712A (en) | Carbacyclin analogs | |
| US5284858A (en) | Prostaglandins E and anti ulcers containing same | |
| US5886034A (en) | Prostaglandins E and anti ulcers containing same | |
| DE4024347A1 (de) | Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung | |
| JPH0324457B2 (enExample) | ||
| DE69610481T2 (de) | Prostaglandine und verfahren zu deren herstellung | |
| DE69311126T2 (de) | ISOCARBACYCLIN MIT MODIFIZIERTER ALPHA(a)-KETTE UND VERFAHREN ZU DESSEN HERSTELLUNG | |
| JPS60169459A (ja) | フエノキシプロスタトリエン酸誘導体の製造法 | |
| DE68910774T2 (de) | Cyclopentanheptencarbonsäurederivate und Verfahren zu ihrer Herstellung. | |
| DE2945781A1 (de) | Prostacyclinzwischenprodukte und protacyclinanaloge | |
| DE3689338T2 (de) | Isocarbacyclinderivate. | |
| DE69502517T2 (de) | Difluorprostacycline, Zwischenprodukte und Verfahren zu deren Herstellung | |
| DE3338832C2 (enExample) | ||
| JPS595155A (ja) | プロスタグランジンｄ類似化合物 | |
| DE2626288C2 (de) | Verfahren zur Herstellung von Prostaglandinzwischenprodukten durch stereoselektive Reduktion | |
| EP0558570B1 (de) | Cyclopentanetherderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung | |
| JPS6022708B2 (ja) | プロスタグランジン類似化合物 | |
| DE2654668A1 (de) | Verfahren zur herstellung von verbindungen des prostaglandintyps und nach diesem verfahren erhaltene produkte | |
| JP2774381B2 (ja) | α鎖修飾イソカルバサイクリン類およびその製造法 | |
| EP0113311B1 (de) | 5-Fluorcarbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| US5206416A (en) | Isocarbacyclin derivative | |
| CA1313670C (en) | Carbacyclin analogs | |
| DE3024723A1 (de) | Prostacyclin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate | |
| JPWO1994007838A1 (ja) | α鎖修飾イソカルバサイクリン類およびその製造法 | |
| DE4024345A1 (de) | Cyclopentenderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |